Search Results for ''

Document de Recherche 118, Janvier 2021

Reconsidérations sur la fabrication mondiale et locale de produits médicaux après le COVID-19  Par Germán Velásquez La crise sanitaire mondiale sans précédent provoquée par la pandémie de coronavirus (COVID-19), au cours du premier semestre 2020, ramène (more...)

SouthViews No. 211, 30 December 2020

The Making of the South Centre By Branislav Gosovic A contribution to the institutional history of developing countries’ collective action in the world arena on the occasion of the South Centre’s 25th anniversary as an intergovernmental organization (more...)

Research Paper 127, December 2020

Revisiting the Question of Extending the Limits of Protection of Pharmaceutical Patents and Data Outside the EU – The Need to Rebalance By Daniel Opoku Acquah The European Union (EU) has instituted internal and external measures aimed at protecting and enforcing (more...)

Research Paper 126, December 2020

How Civil Society Action can Contribute to Combating Antimicrobial Resistance By Mirza Alas Portillo One of the key groups of actors that must be recognized for their influential role in shaping health policy outcomes are civil society organizations (CSOs). The (more...)

Panel discussion, 11 December 2020

Guaranteeing Access to Medicines: Reforming Trade and Investment Treaties in the COVID-19 Era Eight months into COVID-19, what is the status of the international investment regime and access to essential medicines? The GDP Center’s Working Group on Trade and Access to Medicines (more...)

Webinar with MSF on 7 December 2020

Access to Covid-19 Vaccines, Medicines and Diagnostics: Voluntary and Compulsory Licenses, TRIPS Waiver The South Centre and Médecins Sans Frontières Access Campaign organized a Webinar on 7 December at 2.00p.m. CET on patent licensing in the context (more...)
0

Your Cart